Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 22

Sort by

Sort Order Select

Journal Articles

Busulfan-Based Intensified Myeloablative Conditioning Regimen Allogeneic Hematopoietic Cell Transplantation for Juvenile Myelomonocytic Leukemia-Single Center Study

Yun Wang, Ruijuan Sun, Yanli Zhao, Zhijie Wei, Min Xiong, Deyan Liu, Peihua Lu, Yue Lu

Blood (2024) 144 (Supplement 1): 7328.

https://doi.org/10.1182/blood-2024-202905

Published: 2024

Journal Articles

Comparable OS and Gffs of ATLG Vs. Ratg for Gvhd Prophylaxis in Pediatric AA Patients Undergoing Transplantation

Li Nannan, Yue Lu, Deyan Liu, Min Xiong, Yanli Zhao, Ruijuan Sun, Zhijie Wei, Xingyu Cao, Jiarui Zhou, Jianping Zhang, Peihua Lu

Blood (2024) 144 (Supplement 1): 3537.

https://doi.org/10.1182/blood-2024-209027

Published: 2024

Journal Articles

Long-Term Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation for 532 Patients with KMT2A-Rearranged Acute Leukemia

Ruijuan Sun, Yue Lu, Jian-Ping Zhang, Jiarui Zhou, Deyan Liu, Yanli Zhao, Zhijie Wei, Min Xiong, Xingyu Cao, Peihua Lu

Blood (2024) 144 (Supplement 1): 3546.

https://doi.org/10.1182/blood-2024-206907

Published: 2024

Journal Articles

A Long-Term Follow-up Retrospective Study of the Clinical Efficacy of Haploidentical Hematopoietic Stem Cell Transplantation for Early T-Precursor Acute Lymphoblastic Leukemia and T-Lymphoblastic Lymphoma

Xingyu Cao, Yue Lu, Jian-Ping Zhang, Deyan Liu, Zhijie Wei, Yanli Zhao, Jiarui Zhou, Min Xiong, Ruijuan Sun, Jing Long, Peihua Lu

Blood (2024) 144 (Supplement 1): 4934.

https://doi.org/10.1182/blood-2024-204579

Published: 2024

Journal Articles

Critical role of tripartite fusion and LBD truncation in certain RARA - and all RARG -related atypical APL

Blood (2024) 144 (14): 1471–1485.

https://doi.org/10.1182/blood.2024023883

Published: 2024

Includes: Supplemental data

Journal Articles

Efficacy and Safety Analysis of Prophylactic Brentuximab Vedotin Administration after Pediatric Acute Leukemia Haploidentical Hematopoietic Stem Cell Transplantation

Huili Zhu, Xingyu Cao, Yue Lu, Yanli Zhao, Jianping Zhang, Deyan Liu, Min Xiong, Ruijuan Sun, Hongxing Liu, Zhijie Wei

Blood (2023) 142 (Supplement 1): 7009.

https://doi.org/10.1182/blood-2023-184500

Published: 2023

Journal Articles

CD7 CAR-T Therapy Followed By a Second Transplant for T-Cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma Patients Who Relapsed after a Prior Transplant

Xingyu Cao, Jianping Zhang, Yue Lu, Yanli Zhao, Deyan Liu, Min Xiong, Zhijie Wei, Jiarui Zhou, Xian Zhang, Junfang Yang, Hongxing Liu, Peihua Lu

Blood (2023) 142 (Supplement 1): 2155.

https://doi.org/10.1182/blood-2023-186030

Published: 2023

Journal Articles

A Parallel Comparison of the Safety and Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation for Refractory and Relapsed T-ALL/Lbl Patients Who Achieved Complete Remission with CD7 CAR-T Versus Patients Who Achieved First Complete Remission with Chemotherapy before Transplantation

Xingyu Cao, Jianping Zhang, Yue Lu, Yanli Zhao, Deyan Liu, Min Xiong, Ruijuan Sun, Zhijie Wei, Jiarui Zhou, Xian Zhang, Junfang Yang, Hongxing Liu, Sr., Peihua Lu

Blood (2023) 142 (Supplement 1): 3611.

https://doi.org/10.1182/blood-2023-185696

Published: 2023

Journal Articles

Addition of Ruxolitinb to Corticosteroids As First-Line Therapy for High-Risk Acute Graft Versus Host Disease in Allogeneic Peripheral Blood Stem Cell Transplantation

Liping Dou, Yanli Zhao, Lei Deng, Fang Zhou, Nan Wang, Xiangshu Jin, Fei Li, Liangding Hu, Daihong Liu

Blood (2022) 140 (Supplement 1): 1381–1382.

https://doi.org/10.1182/blood-2022-158162

Published: 2022

Journal Articles

Short-Term Efficacy and Safety of Haplo Hematopoietic Stem Cell Transplantation for Refractory and/or Relapsed Leukemia

Wei Zhao, Min Xiong, Yanli Zhao, Man Chen, Hui Wang, Peihua Lu

Blood (2022) 140 (Supplement 1): 12961–12962.

https://doi.org/10.1182/blood-2022-166724

Published: 2022

Journal Articles

Aberrant Dntt Expression, TdT-Aided Gene Length Mutations, and Prognosis Relevance in ATG/Alg Based Regimen Allo-HSCT in Acute Myeloid Leukemias

Xiaosu Zhou, Daijing Nie, Yang Zhang, Zhixiu Liu, Jianping Zhang, Yanli Zhao, Fang Wang, Jiancheng Fang, Panxiang Cao, Xue Chen, Xiaoli Ma, Jiaqi Chen, Qisheng Wu, Peihua Lu, Hongxing Liu

Blood (2021) 138 (Supplement 1): 2367.

https://doi.org/10.1182/blood-2021-150355

Published: 2021

Journal Articles

A Novel CMV-Specific TCR-T Cell Therapy Is Effective and Safe for Refractory CMV Infection after Allogeneic Hematopoietic Stem Cell Transplantation

Xingyu Cao, Guangna Liu, Jianping Zhang, Yanli Zhao, Hua Chen, Hongli Zheng, Wei Rui, Lemei Jia, Xueqiang Zhao, Xin Lin, Peihua Lu

Blood (2021) 138 (Supplement 1): 3848.

https://doi.org/10.1182/blood-2021-146446

Published: 2021

Journal Articles

Clinical Analysis of Air-Leak Syndrome Following Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Patients

Wei Zhao, Man Chen, Yanli Zhao, Hui Wang, Peihua Lu, Min Xiong

Blood (2021) 138 (Supplement 1): 4870.

https://doi.org/10.1182/blood-2021-152138

Published: 2021

Journal Articles

To Explore the Effect of Haploidentical Transplantation in the Treatment of Pediatric T-ALL with Sil-TAL1 Fusion Gene Positive and Analysis of Prognostic Factors

Huili Zhu, MD, Peihua Lu, MD, Deyan Liu, Yanli Zhao, Jiarui Zhou, Jianping Zhang, Xingyu Cao, Yue Lu, Zhijie Wei

Blood (2020) 136 (Supplement 1): 18–19.

https://doi.org/10.1182/blood-2020-139583

Published: 2020

Journal Articles

Significant Long-Term Benefits of CAR T-Cell Therapy Followed By a Second Allo-HSCT for Relapsed/Refractory (R/R) B-Cell Acute Lymphoblastic Leukemia (B-ALL) Patients Who Relapsed after an Initial Transplant

Jianping Zhang, Junfang Yang, Xian Zhang, MD, Jingjing Li, Xingyu Cao, Yanli Zhao, Zhijie Wei, Deyan Liu, Min Xiong, Yue Lu, Jiarui Zhou, Ruijuan Sun, Peihua Lu, MD

Blood (2020) 136 (Supplement 1): 40–41.

https://doi.org/10.1182/blood-2020-136014

Published: 2020

Journal Articles

Alternative Donor and Disease-Specific Conditioning Regimen Hematopoietic Stem Cell Transplantation for Inherited Bone Marrow Failure Syndromes

Fang Xu, Min Xiong, Ruijuan Sun, Yanli Zhao, Jianping Zhang, Xingyu Cao, Deyan Liu, Zhijie Wei, Jiarui Zhou, Yue Lu, Peihua Lu, Daopei Lu

Blood (2019) 134 (Supplement_1): 2047.

https://doi.org/10.1182/blood-2019-125695

Published: 2019

Journal Articles

CD19-CAR-T Therapy Followed By Allogeneic Hematopoietic Stem Cell Transplantation in Refractory/Relapsed and High Risk B-Cell Acute Lymphoblastic Leukemia

Yanli Zhao, Jianping Zhang, Deyan Liu, Min Xiong, Zhijie Wei, Ruijuan Sun, Jiarui Zhou, Yue Lu, Xingyu Cao, Junfang Yang, MD, Xian Zhang, PhD, Hui Wang, PhD, Hongxing Liu, MD, Peihua Lu, Daopei Lu

Blood (2018) 132 (Supplement 1): 2660.

https://doi.org/10.1182/blood-2018-99-118852

Published: 2018

Journal Articles

Allogeneic Transplantation for Minimal Residual Disease Negative Acute Lymphoblastic Leukemia According to 2016 Who Classification: A Single Center Retrospective Analysis

Xingyu Cao, Deyan Liu, Jianping Zhang, Zhijie Wei, Min Xiong, Yue Lu, Yanli Zhao, Jiarui Zhou, Ruijuan Sun, Hongxing Liu, MD

Blood (2018) 132 (Supplement 1): 5786.

https://doi.org/10.1182/blood-2018-99-116119

Published: 2018

Journal Articles

Unmanipulated Haploidentical Transplant for Acquired Severe Aplastic Anemia Achieved Comparable Outcomes with Unrelated Donor Transplant in Adult and Children Patients

Yue Lu, Ruijuan Sun, MD, Yanli Zhao, Xingyu Cao, Min Xiong, Jiangping Zhang, Dao-Pei Lu, MD, Hongxing Liu, MD

Blood (2017) 130 (Supplement 1): 4565.

https://doi.org/10.1182/blood.V130.Suppl_1.4565.4565

Published: 2017

Journal Articles

Safety and Immunogenicity Of Inactivated Varicella-Zoster Virus Vaccine In Adults With Hematologic Malignancies Receiving Treatment With Anti-CD20 Monoclonal Antibodies

Shelly McNeil, Robert Betts, Steven Lawrence, Andrea Velardi, Eva Kimby, Marco Pagnoni, Jon Stek, Yanli Zhao, Ivan Chan, Ingi Lee, Janie Parrino

Blood (2013) 122 (21): 2290.

https://doi.org/10.1182/blood.V122.21.2290.2290

Published: 2013

NARROW

Busulfan-Based Intensified Myeloablative Conditioning Regimen Allogeneic Hematopoietic Cell Transplantation for Juvenile Myelomonocytic Leukemia-Single Center Study

Comparable OS and Gffs of ATLG Vs. Ratg for Gvhd Prophylaxis in Pediatric AA Patients Undergoing Transplantation

Long-Term Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation for 532 Patients with KMT2A-Rearranged Acute Leukemia

A Long-Term Follow-up Retrospective Study of the Clinical Efficacy of Haploidentical Hematopoietic Stem Cell Transplantation for Early T-Precursor Acute Lymphoblastic Leukemia and T-Lymphoblastic Lymphoma

Critical role of tripartite fusion and LBD truncation in certain RARA - and all RARG -related atypical APL

Efficacy and Safety Analysis of Prophylactic Brentuximab Vedotin Administration after Pediatric Acute Leukemia Haploidentical Hematopoietic Stem Cell Transplantation

CD7 CAR-T Therapy Followed By a Second Transplant for T-Cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma Patients Who Relapsed after a Prior Transplant

A Parallel Comparison of the Safety and Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation for Refractory and Relapsed T-ALL/Lbl Patients Who Achieved Complete Remission with CD7 CAR-T Versus Patients Who Achieved First Complete Remission with Chemotherapy before Transplantation

Addition of Ruxolitinb to Corticosteroids As First-Line Therapy for High-Risk Acute Graft Versus Host Disease in Allogeneic Peripheral Blood Stem Cell Transplantation

Short-Term Efficacy and Safety of Haplo Hematopoietic Stem Cell Transplantation for Refractory and/or Relapsed Leukemia

Aberrant Dntt Expression, TdT-Aided Gene Length Mutations, and Prognosis Relevance in ATG/Alg Based Regimen Allo-HSCT in Acute Myeloid Leukemias

A Novel CMV-Specific TCR-T Cell Therapy Is Effective and Safe for Refractory CMV Infection after Allogeneic Hematopoietic Stem Cell Transplantation

Clinical Analysis of Air-Leak Syndrome Following Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Patients

To Explore the Effect of Haploidentical Transplantation in the Treatment of Pediatric T-ALL with Sil-TAL1 Fusion Gene Positive and Analysis of Prognostic Factors

Significant Long-Term Benefits of CAR T-Cell Therapy Followed By a Second Allo-HSCT for Relapsed/Refractory (R/R) B-Cell Acute Lymphoblastic Leukemia (B-ALL) Patients Who Relapsed after an Initial Transplant

Alternative Donor and Disease-Specific Conditioning Regimen Hematopoietic Stem Cell Transplantation for Inherited Bone Marrow Failure Syndromes

CD19-CAR-T Therapy Followed By Allogeneic Hematopoietic Stem Cell Transplantation in Refractory/Relapsed and High Risk B-Cell Acute Lymphoblastic Leukemia

Allogeneic Transplantation for Minimal Residual Disease Negative Acute Lymphoblastic Leukemia According to 2016 Who Classification: A Single Center Retrospective Analysis

Unmanipulated Haploidentical Transplant for Acquired Severe Aplastic Anemia Achieved Comparable Outcomes with Unrelated Donor Transplant in Adult and Children Patients

Safety and Immunogenicity Of Inactivated Varicella-Zoster Virus Vaccine In Adults With Hematologic Malignancies Receiving Treatment With Anti-CD20 Monoclonal Antibodies

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only